Cargando…
Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management
Atrial fibrillation continues to be a significant source of morbidity and mortality worldwide. Effective anticoagulation remains the cornerstone of outpatient and inpatient treatment. The use of the new generation of anticoagulants (NOACs) continues to grow. Recently published data indicate their co...
Autores principales: | Shamoun, Fadi, Obeid, Hiba, Ramakrishna, Harish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503583/ https://www.ncbi.nlm.nih.gov/pubmed/26221593 http://dx.doi.org/10.1155/2015/424031 |
Ejemplares similares
-
Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
por: Mookadam, Martina, et al.
Publicado: (2015) -
Perioperative atrial fibrillation: A systematic review of evolving therapeutic options in pharmacologic and procedural management
por: Schleifer, J. William, et al.
Publicado: (2015) -
Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
por: O'Callaghan, Marissa, et al.
Publicado: (2018) -
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
por: Joppa, Stephanie A., et al.
Publicado: (2018) -
Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)